Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.
Smith+Nephew launched its CARTIHEAL AGILI-C cartilage repair implant commercially in Europe, following its 2024 US introduction. The aragonite-based biphasic scaffold is initially rolling out in Austria, Belgium, France, the Netherlands, Portugal, Spain, Switzerland and the UK, with wider European expansion planned.
Key figures
- Employees
- 17000
- Launch markets
- ["Austria","Belgium","France","Netherlands","Portugal","Spain","Switzerland","UK"]
- Annual revenue 2025
- $6.2 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.